Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 5-15, September 2007

Classification of the cardiomyopathies

  • Steven D. Colan

      Affiliations

    • Corresponding Author InformationDepartment of Cardiology, Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, United States. Tel.: +1 6173557893; fax: +1 6177396282.

Children's Hospital, Harvard Medical School, Boston, MA, United States

Abstract 

The cardiomyopathies have represented a challenging group of disorders to classify. The diversity of the disorders and the fact that many have only been recognized as clinical entities over the past 25 years continues to impede progress. Classification systems based on morphology, physiology, and etiology have been attempted and most systems are based on a combination of these three organizing principles. Despite these efforts, there are significant limitations with each of these systems, with many ambiguous cases, some newer cardiomyopathies that do not readily fit within the existing nomenclature systems, and a general sense of dissatisfaction with the mixed bases for these classification systems (phenotype and etiology). The continuing and accelerating molecular definition of the causes of many of these disorders has led a number of investigators to suggest that a classification based on the genetic basis for many of these diseases might overcome some of the limitations of prior systems. An American Heart Association Consensus Panel was convened to consider this issue and their scientific statement was published in 2006. This consensus document reviewed the problems associated with the phenotypic-based classification of the cardiomyopathies and proposed a new system that represents a significant departure from current clinical use. The changes recommended by this panel included implementing the presence or absence of a genetic etiology as the first order organizing principle. The panel recommended that use of the term hypertrophic cardiomyopathy be restricted to individuals with sarcomeric gene defects that manifest as a hypertrophic cardiomyopathic phenotype. They also recommended the inclusion of cardiac disorders that manifest primarily as arrhythmias (ion channelopathies) as forms of cardiomyopathies. This article reviews the implications of these recommendations and compares the existing and the proposed systems of classification.

Keywords: Cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Restrictive cardiomyopathy, Nomenclature, Classification

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by NIH NHLBI grant RO1 HL53392 and the Children's Cardiomyopathy Foundation, Inc.

PII: S1058-9813(07)00004-5

doi:10.1016/j.ppedcard.2007.05.003

Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 5-15, September 2007